Biogen Spinoff Bioverativ Is A Buy By: Benzinga via Benzinga September 20, 2017 at 10:51 AM EDT Analysts at Argus Research turned bullish on Bioverativ Inc (NASDAQ: BIVV) as the company could establish itself as a profitable biotech ... Read More >> Related Stocks: Biogen Idec